Katherine Canada

Ms. Katherine Canada


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Cerebral Cortex
Verified
Journal Article
Closed access
KCKatherine Canada
Katherine Canada
TETanya M Evans
Tanya M Evans
KPKevin A Pelphrey
Kevin A Pelphrey
White matter, comprising approximately 50% of the human brain, is crucial for efficient neuronal signaling and a wide range of brain functions, including social cognition, sensation, memory, motor control, and information integration across cortical brain regions in the service of perception and cognition. White matter, composed of myelinated axons, results from complex interactions between different cell types, with oligodendrocytes (OLs) and microglia playing integral roles. Microglia, the brain's resident immune cells, regulate oligodendrogenesis through phagocytosis and molecular signaling, for example through cytokines, which promote and inhibit maturation stages of OL lineage cells. Maternal immune activation (MIA) is a recognized risk factor for neurodevelopmental disorders, especially autism spectrum disorder (ASD). The physiological presentation of ASD includes white matter abnormalities and immune dysregulation. Emerging evidence indicates that MIA may reduce microglial reactivity and alter cytokine release in offspring, potentially disrupting the delicate balance required for proper white matter development. Understanding the intricate interplay between oligodendrocytes, microglia, inflammation, and white matter development in the context of MIA provides valuable insights into the etiology of and core symptoms of ASD and possible therapeutic targets.

1 April 2025 in Journal of Neurophysiology
Verified
Journal Article
Closed access
KCKatherine Canada
Katherine Canada
TETanya M. Evans
Tanya M. Evans
KPKevin A. Pelphrey
Kevin A. Pelphrey
Autism spectrum disorder (ASD) is characterized by deficits in social communication and restricted, repetitive behavioral patterns. Although other physiological presentations in individuals with ASD are heterogeneous, neuroimaging studies have consistently revealed a developmental pattern of initial white matter hypermyelination followed by reduced myelination compared with typically developing peers. Multiple studies have demonstrated that core ASD symptoms, including impairments in social skills, language acquisition, learning capabilities, motor performance, and sensory processing, correlate significantly with white matter dysregulation measured through diffusion tensor imaging (DTI). Longitudinal studies have shown that decreased gut microbiome diversity, particularly reductions in beneficial bacteria such as Bifidobacterium and Lactobacillus, correlates with symptom severity. Emerging mechanistic evidence suggests bidirectional relationships between microbiome composition and white matter development, both directly through metabolites like short-chain fatty acids (SCFAs) that regulate oligodendrocyte function and subsequent myelination, and indirectly through modulation of neuroinflammatory pathways. By integrating molecular-level gut physiology findings with macro-level brain imaging data, we may identify novel therapeutic approaches targeting the gut-brain axis in ASD management.

30 December 2025 in Biology
Verified
Journal Article
Open access
PDF file
EHEdric Alexander Han
Edric Alexander Han
KCKatherine Canada
Katherine Canada
MPMeghan H. Puglia
Meghan H. Puglia
KPKevin A. Pelphrey
Kevin A. Pelphrey
TETanya M. Evans
Tanya M. Evans
Autism spectrum disorder (ASD) arises from complex genetic and environmental influences. Despite its prevalence and being the focus of study for several decades, its causes and their underlying mechanisms are still not fully understood. However, one consistent causal mechanism of interest is epigenetic modification. While some risk factors, such as maternal stress, nutrition, and environmental toxins, have a more established epigenetic connection, early-life stress (ELS) in the postnatal years is less studied but may be just as impactful in terms of phenotypic outcomes. A major intermediary between ELS and ASD is likely the hypothalamic–pituitary–adrenal axis (HPA axis), which has been shown to be epigenetically modified by ELS and whose genes and dysfunction overlap with ASD genes and symptoms. In this narrative review, we synthesize human and animal evidence to examine the relationships between ELS and ASD through epigenetic regulation of a non-exhaustive list of autism candidate genes involved in the HPA axis, including NR3C1, FKBP5, MECP2, GAD1, RELN, SHANK3, OXTR, and BDNF. We discuss how ELS-induced epigenetics may modulate HPA axis negative feedback, and how epigenetic alterations in this pathway and associated genes could affect ASD phenotypes.

4 November 2026 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
KCKatherine Canada
Katherine Canada
KBKathryn Brinson
Kathryn Brinson
SBSameer S. Bajikar
Sameer S. Bajikar
TETanya Evans
Tanya Evans
KPKevin Pelphrey
Kevin Pelphrey
Autism spectrum disorder affects 1 in 31 people yet exhibits remarkable genetic heterogeneity with over 1000 genes identified in autistic populations producing convergent neurobiological phenotypes through not yet understood mechanisms. Here, we employed systems-level network analysis to test if diverse autism risk genes converge onto common cellular vulnerabilities across brain cell types. Using 1238 autism-associated genes from the Simons Foundation Autism Research Initiative (SFARI) database, we stratified genes by cell-type-specific expression patterns and constructed protein-protein interaction networks to map functional clusters and identify critical connector proteins. Through permutation-based statistical analysis, we identified convergent downstream proteins targets, representing molecular vulnerabilities where multiple autism-associated protein pathways converge for miscoordination of cellular function. Network analysis revealed cell-type-specific vulnerability signatures: SYN1 in inhibitory neurons, GRIN/DLG/CAMK2 proteins in excitatory neurons, GRIA2A/DLG4/GRIN2 in oligodendrocyte precursor cells, ACTL6B in oligodendrocytes, and ARHGAP/DOCK proteins in astrocytes. Remarkably, these computationally predicted targets have been independently validated in human genetics and autism research, demonstrating that network-based convergent vulnerability analysis successfully identifies critical nodes where diverse genetic insults disrupt coordinated cellular responses. This framework provides a molecular basis for understanding autism pathophysiology and identifies promising targets for intervention in the treatment of neurodevelopmental disorders.

15 December 2025 in Journal of Science Policy & Governance
Verified
Journal Article
Closed access
MLMichael C Lemke
Michael C Lemke
AGAlissa Ganser
Alissa Ganser
JRJane Remfert
Jane Remfert
JDJulia Davis
Julia Davis
TVTrisha Vaidyanathan
Trisha Vaidyanathan
JEJ. Maxwell Ebert
J. Maxwell Ebert
Open burning/open detonation (OB/OD) facilities pose a significant contamination threat to local municipalities. The OB/OD disposal method of munitions manufacturing waste is utilized by the Radford Army Ammunition Plant (RAAP) in Virginia and other locations. The OB/OD exception was originally implemented to facilitate the disposal of military explosive waste, and has continued at RAAP since the early 2000s despite safer disposal methods being developed. In accordance with its core mandate to safeguard the public and the environment, the US Environmental Protection Agency (EPA) has proposed revisions to the exemptions for OB/OD. However, based on our analysis of the disease burden within the RAAP watershed in Virginia and West Virginia, as well as the policy itself, it is evident the EPA proposal falls short of adequately safeguarding communities from the harmful effects of the OB/OD practices.